Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.

Source:http://linkedlifedata.com/resource/pubmed/id/15188458

Download in:

View as

General Info

PMID
15188458